Today: 10 June 2026
CleanSpark stock jumps 7% as bitcoin rallies; miners rise with February earnings in view

CleanSpark stock jumps 7% as bitcoin rallies; miners rise with February earnings in view

New York, Jan 5, 2026, 11:00 EST — Regular session

  • CleanSpark shares rose about 7% as bitcoin held near $94,000, lifting U.S.-listed miners.
  • Traders focused on mining economics after a JPMorgan note flagged a second monthly drop in network hashrate.
  • Next major catalyst is CleanSpark’s quarterly report expected on Feb. 5.

CleanSpark Inc shares rose about 7% on Monday, tracking a rally in bitcoin and a broader lift in U.S.-listed crypto miners. The stock was up at $12.37 in late morning trade.

The move matters now because bitcoin miners’ cash generation is tightly linked to the token’s price: higher prices typically mean richer block rewards in dollar terms. Bitcoin was up 2.8% at roughly $93,862, helping buoy sentiment across the group.

Mining investors are also watching signs that competition may be easing. JPMorgan analysts Reginald Smith and Charles Pearce wrote the bitcoin network’s computing power, or hashrate, fell again, citing “an average of 1,045 EH/s in December.” Hashrate is a proxy for how much computing muscle is chasing the same pool of bitcoin rewards. CoinDesk

Peers moved in the same direction. Marathon Digital gained about 5.8% and Riot Platforms added roughly 3.4% in the regular session.

CleanSpark traded between $11.95 and $12.54 on Monday after closing at $11.55 on Friday, when it snapped a six-session losing streak, according to market data.

CleanSpark’s last operational update, released in early December, showed it mined 587 bitcoin in November and held 13,054 bitcoin at month-end, with part of that balance posted as collateral or receivable, the company said. It also reported 1.45 gigawatts of power under contract — the electrical capacity that underpins how fast a miner can scale.

The company has also leaned on capital markets to fund expansion and balance-sheet moves. In that same update, CleanSpark said it repurchased about 30.6 million shares for $460 million in connection with its $1.15 billion zero-coupon convertible notes offering.

But the leverage cuts both ways. A sharp pullback in bitcoin, a rise in mining difficulty, or higher power costs can squeeze margins quickly, and the sector tends to reprice fast when the token turns lower.

Stock Market Today

  • Sanofi Halts Phase III Neurology Drug Study After Poor Results
    June 10, 2026, 10:35 AM EDT. Sanofi has discontinued the phase III MOBILIZE trial for its riliprubart drug in treating chronic inflammatory demyelinating polyneuropathy (CIDP) after an independent committee found it unlikely to show sufficient efficacy. No new safety concerns were identified. The setback impacts Sanofi's planned 2027 regulatory filing and raises questions about riliprubart's future, despite continued phase III VITALIZE trials. CIDP is a rare nerve disorder causing muscle weakness and sensory loss. Sanofi shares fell in pre-market trading following the announcement, with the stock down nearly 8% year to date compared to a 4% industry gain. Riliprubart, a monoclonal antibody targeting immune pathways, is also in phase II trials for kidney transplant rejection. Sanofi holds a Zacks Rank #3 (Hold).

Latest articles

BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks
Previous Story

BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Next Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

Go toTop